HWM vs RNA · P/E 58, rev $4.86B vs rev $22.6M
Howmet Aerospace Inc (HWM) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
Howmet Aerospace Inc (HWM) is a aerospace & defense company listed on US.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported HWM revenue for 2026-06-30 was $4.86B. Net income was $1.11B. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
HWM currently screens at market cap $100.79B and trailing P/E 58.4. RNA currently screens at market cap $217.5M.
Not investment advice. Open the HWM and RNA stock pages for the full models.
Not investment advice.